Safety Tips for Medication Users During Summer Heat and Sun Exposure
As summer approaches, the Medicines and Healthcare products Regulatory Agency (MHRA) is reminding individuals taking certain medications to exercise caution in warmer weather. Some treatments can hinder the body's ability to stay hydrated, regulate temperature, or cope with sun exposure, leading to increased health risks. This guidance is part of the MHRA's 'Summer-proof your health' campaign, which aims to raise awareness about safe medication use during the hotter months.
Certain commonly prescribed medications, such as diuretics, can lead to fluid loss and a higher likelihood of dehydration. Additionally, some antidepressants and antipsychotics may impair the body's temperature regulation, while beta blockers can diminish the body's response to heat stress. Furthermore, various treatments can heighten sensitivity to sunlight, increasing the risk of sunburn. This includes specific antibiotics like doxycycline and tetracycline, acne medications such as isotretinoin and topical retinoids, and antifungal drugs like voriconazole. Disease-modifying antirheumatic drugs (DMARDs), including methotrexate and azathioprine, used for conditions like rheumatoid arthritis, can also contribute to photosensitivity.
Moreover, proton pump inhibitors (PPIs), which are commonly used to treat acid reflux, have been associated with a very low risk of a lupus-like skin reaction when exposed to sunlight. Common pain relievers like ibuprofen and naproxen may similarly increase sun sensitivity.
To mitigate these risks, the MHRA advises individuals to stay hydrated, avoid sun exposure during peak hours, and utilize protective clothing and sunscreen. It is essential for patients to check the patient information leaflet that accompanies their medication for specific advice regarding sun exposure and hydration, which is also accessible online.
Individuals should be vigilant for signs that their body is struggling in the heat, such as dizziness, headaches, unusual fatigue, confusion, or reduced urination. Skin reactions, including redness, soreness, or blistering after sun exposure, may indicate increased sensitivity due to medication.
Importantly, individuals should not discontinue their prescribed medications during hot weather without consulting a healthcare professional. Anyone uncertain about how their medication may interact with heat or sunlight is encouraged to speak with a pharmacist or GP.
The MHRA's campaign aims to empower individuals to recognize the potential risks associated with their medications during the summer and to take straightforward steps to ensure their safety. Additionally, those experiencing side effects from their medications should communicate with their healthcare provider. The MHRA also encourages reporting side effects through the Yellow Card scheme, which helps enhance the safety of medicines for all users.
The MHRA is the regulatory body responsible for overseeing all medicines and medical devices in the UK, ensuring their efficacy and safety through rigorous, evidence-based evaluations.




